共 50 条
Efficacy and Safety of Endobronchial Ultrasonography with a Guide-sheath for Acute Pulmonary Lesions in Patients with Haematological Diseases
被引:1
作者:
Nakashima, Kei
[1
]
Misawa, Masafumi
[1
]
Otsuki, Ayumu
[1
]
Narita, Kentaro
[2
]
Otsuka, Yoshihito
[3
]
Matsue, Kosei
[2
]
Aoshima, Masahiro
[1
]
机构:
[1] Kameda Med Ctr, Dept Pulmonol, Kamogawa, Japan
[2] Kameda Med Ctr, Dept Haematol, Kamogawa, Japan
[3] Kameda Med Ctr, Dept Lab Med, Kamogawa, Japan
关键词:
adult;
bronchoscopy;
haematologic disease;
image-guided biopsy;
lung disease;
TRANSBRONCHIAL BIOPSY;
DIAGNOSTIC YIELD;
FIBEROPTIC BRONCHOSCOPY;
LUNG-BIOPSY;
COMPLICATIONS;
ULTRASOUND;
INCREASES;
D O I:
10.2169/internalmedicine.6364-20
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objective Acute pulmonary lesions (APLs), defined as an acute infiltrate or nodular lung field, are a major complication in patients with haematological diseases. Recently, endobronchial ultrasonography with a guide sheath (EBUS-GS) was established as a useful technique for diagnosing pulmonary lesions. This study aimed to evaluate the efficacy and safety of EBUS-GS for managing APLs in patients with haematological diseases. Methods Our single-centre, retrospective, observational, single-arm, descriptive study enrolled 22 consecutive adult (>20-year-old) patients with haematological diseases and concomitant APL who underwent EBUS-GS between January 2011 and June 2016 at Kameda Medical Center, Chiba, Japan. The primary endpoint was the contribution of EBUS-GS to clinical decision-making. Secondary endpoints were an adequate tissue collection rate, diagnostic yield, complication rate, and 30-day mortality. Results The median patient age was 70 years old, and 63.6% were men. Acute myeloid leukaemia was the most frequent underlying disease, accounting for 54.5% of patients. The contribution of EBUS-GS to clinical decision-making was recognised in 11 (50.0%) patients. Adequate tissue collection was achieved in 21 (95.5%) patients. The aetiology of the APL was identified in 9 (40.9%) patients. No complications, including severe haemorrhaging and pneumothorax, were observed in any patients, and the 30-day mortality rate was 0%. Conclusion EBUS-GS may be a suitable diagnostic option for APL in patients with haematological diseases. Further larger-scale and randomised controlled trials are needed to confirm our results.
引用
收藏
页码:623 / 632
页数:10
相关论文